FindTrial
Sign In

Developement of Diagnostic and monitoring marker for allergic disease and pulmonary disease

Developement of Diagnostic and monitoring marker for allergic disease and pulmonary disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000112
Enrollment
500
Registered
2011-05-13
Start date
2009-02-12
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Wonkwang University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 5 respiratory disease and health control without respiratory disease

Exclusion criteria

Exclusion criteria: acquired immune deficiency syndrome, or recent chest trauma within 30 days

Design outcomes

Primary

MeasureTime frame
level evaluation (chitinase family, IL-1 family cytokine, IGSF family, Interferon)—

Secondary

MeasureTime frame
Diagnostic Accuracy, role as a monitoring marker (ADA, BNP, Protein, CRP, CEA, Cyfra 21-1, chitinase family, IL-1 family cytokine, IGSF family, Interferon)—

Countries

Korea, Republic of

Contacts

Public ContactDo-Sim Park

Wonkwang University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026